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Neurocysticercosis ( NCC) is a leading cause of seizure and epilepsy worldwide. There are no path
gnomonic features or a typical NCC syndrome. In this communication we describe an interesting case of
multiple NCC in an elderly presenting only with dementia and responded well to steroid and cerebral
decongestant. The case report highlights an uncommon presentation of NCC and recognizing this
reversible cause will avoid unnecessary investigation and delay in treatment.
Copyright  2012, Asia Paciﬁc League of Clinical Gerontology & Geriatrics. Published by Elsevier Taiwan
Open access under CC BY-NC-ND license.LLC.1. Introduction
Neurocysticercosis (NCC) is a common parasitic infection of the
human central nervous system caused by pork tapeworm Taenia
solium. NCC is a serious public health problem in several developing
countries in Latin America, Asia and Africa. It is well known that
NCC, the commonest parasitic brain disease,1 causes epilepsy, focal
neurological signs, intracranial hypertension, stroke and neuro-
psychiatry symptoms.2,3 We report a case of an elderly person
presented with rapidly progressive dementia as the isolated
manifestation of multiple NCC.2. Case report
A 65-year-old right-handed male, postgraduate and clerk by
profession, presented with occipital headache which was moderate
to severe in intensitywith occasional bouts of vomiting of 4months’
duration and a gradual progressive decline in cognitive functions of
3 months’ duration. Initially he had problem in performing his
professional work. He had great difﬁculty in calculation and made
mistakes in his ﬁles, had difﬁculty in comprehension of paragraphs,
forgot information, andmisplacedobjects andﬁles.Hewasunable to
supervise his children’s studies and often lost his temper and
responsed with irritability. There was marked slowness in doing
dailyactivity and thought processes, lack of spontaneity, apathy, anddical Sciences and Research,
(A. Verma).
linical Gerontology & Geriatrics. Plack of interest toward the environment and himself. Gradually he
became unconcerned about his personal hygiene, forgot to eat
meals, andgot lost innewplaces.Hewasunable to recall his address,
telephone numbers, or names of close relatives within a span of
threemonths. His cognitive declinewas severe enough to impair his
personal and occupational performance. His symptoms were
observed by his wife and reported to our hospital.
There was no history suggestive of coronary artery disease,
cerebrovascular disease, head injury, joint pain, photosensitivity or
rashes. A review of the central nervous system did not reveal any
history of loss of consciousness, seizure like activity, abnormal
involuntary body movement, gait ataxia, dysphagia, dysarthria, or
any weakness. There was no history suggestive of diabetes and
hypertension or any past or family history of any similar psychiatric
or neurological illness.
The general physical and systemic examination was normal.
Although he was conscious and alert, he resisted evaluation. Upon
mental state examination, his Folstein’s mini mental status exam-
ination (MMSE) score was 18 (orientation of place 4/5, calculation
2/5, registration 1/3, recall 0/3, language 6/9). Immediate, recent,
and remote memory was impaired and on lobar function testing
using Strub and Black scheme there was impairment in declarative
memory (semantic and episodic), executive function (judgment,
abstract thinking), naming, and visual spatial orientation. The
speechwas relevant and coherent. Therewere no focal neurological
deﬁcits and the cranial nerves were intact. The fundus examination
was normal.
Laboratory investigations included complete blood count,
general blood picture, erythrocyte sedimentation rate, routine
chemistry, liver and renal function tests, enzyme-linkedublished by Elsevier Taiwan LLC. Open access under CC BY-NC-ND license.
Fig. 1. (A) T2 and (B) FLAIR magnetic resonance images of brain, revealing multiple ring lesions with prominent hyopintensity in centre surrounded by hyperintensity at the
periphery with eccentric scolex scattered throughout gray and white matter.
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virus, and collagen vascular proﬁle, all of which were within the
normal limits. Thyroid function tests and vitamin B12 levels were
within normal range. Electroencephalogram was normal.
Magnetic resonance imaging revealed multiple cysts involving all
of the cerebral cortex and some of the cysts had prominent
scolex. There was adjoining hyperintensity on T2 and FLAIR
images in a few of the lesions (Fig. 1). The ELISA to IgG antibody
against Taenia solium glycoprotein in serum was positive. The
patient was diagnosed as a probably case of NCC based on the
revised diagnostic criteria of NCC by Del Bruto et al.4 We excluded
the other causes like tuberculomas, fungal granuloma, toxoplas-
mosis and tumors.
The patient was offered a steroid (prednisolone) 1 mg/kg body
weight for 28 days followed by acetazolamide 250 mg twice daily
for 2 months. Therewas improvement in cognitive functions after 2
weeks, the headache subsided and MMSE score improved to
24(calculation 4/5, registration 3/3, recall 2/3). Hewas able to do his
ofﬁcial work independently after 6 months.
3. Discussion
NCC is a pleomorphic disease whose manifestation varies with
the number, size, and topography of the lesion and the intensity of
immune response of host to parasite. In this report we describe
a patient presenting with dementia as the only manifestation of
multiple NCC in the absence of any focal neurological deﬁcit or
seizure or features of raised intracranial hypertension.
Although the neuropsychiatric dimension of NCC was reported
earlier, there are reports of NCC presented with psychiatric and
intellectual impairment,5 and with dementia as an isolated mani-
festation.6 Patients with NCC often display cognitive impairment.
Forlenza et al7 reviewed 38 cases of NCC and reported psychiatric
illness and cognitive decline in 65.8% and 87.5% of cases, respec-
tively. Depression was the most frequent psychiatric diagnosis
(52.6%) and 14.2% of the patients were psychotic. Mild to moderate
cognitive deﬁcits were more common than frank dementia. Inter-
estingly, the number, type of brain lesions, use of corticosteroids, or
epilepsy did not correlate signiﬁcantly with the severity ofpsychiatric symptoms. Andrade et al8 in a cross-sectional
controlled study reported dementia in 5 (12.5%) out of 40
patients with NCC and the assessment of neuropsychological
function of NCC cases showed signiﬁcant impairment in executive
function, memory, constructive praxis, and verbal ﬂuency
compared with healthy controls and epilepsy controls.
Dementia syndrome observed in patients with NCC could be
a combined effect, resulting from multiple parasitic and vascular
lesions, disrupting frontal-parietal-temporal networks related to
intellectual functioning in patients with vulnerable brains (because
of repeated epileptic seizures, low educational levels, and advanced
age). The results of this study suggest that dementia occurs
frequently in patients with untreated NCC, and it is reversible in
most.9 Another potential mechanism postulated for cognitive
decline is an inﬂammatory reaction accompanying the death of the
parasite with edema and dysfunction of perilesional tissue.
Guidelines for treatment of NCCmust be individualized in terms
of number and location of lesions, as well as based on the viability
of the parasites within the nervous system. The Cochrane Database
review on drugs for treating NCC concludes that there is insufﬁcient
evidence to assess whether cysticidal therapy in NCC is associated
with beneﬁcial effects.10
Three major arguments against the use of cysticidal therapy in
NCC have been raised: (1) there are immediate risks because of
neurologic symptoms due to the acute inﬂammation that results
from the death of the cysts; (2) the long-term prognosis of the
underlying seizure disorder may worsen because of increased scar-
ring due to the acute inﬂammation; and (3) treatment may be
unnecessary since most cysts recess spontaneously within a short
period. Corticosteroids are frequently used to decrease neurological
symptoms due to the death of the parasite and are the primary
management for chronic cysticercosis arachnoiditis or encephalitis.
Mannitol, at doses of 2 g/kg/day, is also used for acute intracranial
hypertension secondary toNCC.11We treatedourpatientwith steroid
and osmotic diuretics with dramatic improvement in symptoms.
We conclude that our case report is a rare nonepileptic mani-
festation of a very common endemic problem, NCC. It is important
that the clinician should be familiar with this rare presentation as
the dementia is reversible inmost cases when diagnosed at an early
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investigation and delays in treatment.
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